The Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency.
Regulators said Monday they have received more than 30 reports of liver damage in patients taking alli and Xenical, the prescription version of the drug. The reports, submitted between 1999 and October 2008, included 27 hospitalized patients, and six who suffered liver failure.
FDA probes weight-loss pill alli over liver damage reports
An Indiana University undergraduate, a psychiatric researcher and a digital arts alumnus are working to bring...
Air in the U.S. has gotten cleaner for decades, adding years to people's lives and preventing...
